Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.38 | N/A |
PEG Ratio (TTM) | -0.34 | N/A |
P/S Ratio (TTM) | 1.53 | N/A |
P/B Ratio (TTM) | -279.48 | N/A |
P/FCF Ratio (TTM) | -0.35 | N/A |
Price to 5YR AVG Earnings Ratio | -1.10 | N/A |
Price to 5YR AVG FCF Ratio | -0.17 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -64.62% | N/A |
ROE (TTM) | -322.46% | N/A |
Net Profit Margin (TTM) | -565.74% | N/A |
ROIC 5YR AVG | -76.54% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.97% | 4.82% | 23.20% |
Revenue | 13.23% | 114.86% | 212.57% |
Net Income | 1.61% | -3.80% | 12.34% |
Cash Flow | -88.70% | -18.33% | 4.58% |
Health (7%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.51 | N/A |
Quick Ratio (TTM) | 0.33 | N/A |
D/E Ratio (TTM) | -12.20 | N/A |
Interest Coverage (TTM) | -19.69 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.47 | N/A |
Shares Outstanding Growth 5YR AVG | 16.67% | N/A |